Physicochemical Descriptors

Property Name Value
Molecular Formula C21H37GdN4O15
Molecular Weight 742.79
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
None Diagnostic agent DailyMed

Indications

Mesh Heading Maximum Phase Reference
Neoplasm Metastasis Phase 2 ClinicalTrials
Peripheral Arterial Disease Phase 3 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
19.93
Nervous system disorders
16.44
Skin and subcutaneous tissue disorders
14.58
Musculoskeletal and connective tissue disorders
10.93
Psychiatric disorders
10.14
Injury, poisoning and procedural complications
7.16
Respiratory, thoracic and mediastinal disorders
3.3
Gastrointestinal disorders
3.21
Immune system disorders
3.15
Cardiac disorders
2.81
Vascular disorders
2.03

Cross References

Resources Reference
ChEMBL CHEMBL1200431
FDA SRS RH248G8V27
PubChem 55466